List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 19 studies with search of: Open Studies | "Hypotrichosis"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis
Condition: Hypotrichosis
Interventions: Drug: LATISSE® (bimatoprost ophthalmic 0.03% solution);   Drug: vehicle sterile solution
2 Recruiting Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin
Condition: Hypotrichosis
Interventions: Drug: Treatment period one (0-6 months): Bimatoprost 0.03% sterile solution; Treatment period two (6-12 months): Bimatoprost 0.03% sterile solution;   Drug: Treatment period one (0-6 months): vehicle sterile solution; Treatment period two (6-12 months): Bimatoprost 0.03% sterile solution;   Drug: Treatment period one (0-6 months): Bimatoprost 0.03% sterile solution; Treatment period two (6-12 months): vehicle sterile solution
3 Not yet recruiting Safety and Efficacy of Bimatoprost Solution in Treating Chemotherapy-induced Eyelash Loss or Hypotrichosis in Children
Condition: Eyelash Hypotrichosis
Interventions: Drug: bimatoprost ophthalmic solution 0.03%;   Drug: Vehicle Sterile Solution
4 Not yet recruiting Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence
Condition: Eyelash Hypotrichosis
Interventions: Drug: bimatoprost ophthalmic solution 0.005%;   Drug: bimatoprost ophthalmic solution 0.015%;   Drug: bimatoprost ophthalmic solution 0.03%
5 Not yet recruiting AVODART® Alopecia Post-marketing Surveillance (PMS)
Condition: Alopecia
Intervention: Drug: AVODAR®
6 Not yet recruiting Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata
Condition: Alopecia Areata
Interventions: Device: Subcutaneous injection luer syringe;   Device: DERMOJET (a syringe without a needle)
7 Not yet recruiting The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis
Conditions: Recalcitrant Alopecia Totalis;   Recalcitrant Alopecia Universalis
Intervention: Drug: Botulinum toxin A
8 Recruiting Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss
Condition: Female Pattern Hair Loss
Interventions: Drug: Spironolactone;   Drug: Minoxidil
9 Not yet recruiting Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
Condition: Alopecia
Intervention: Drug: AS101
10 Not yet recruiting Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants
Conditions: Alopecia;   Breast Cancer
Interventions: Drug: bimatoprost ophthalmic solution;   Other: placebo
11 Recruiting Treatment of Androgenetic Alopecia in Females, 9 Beam
Conditions: Androgenetic Alopecia;   Hair Loss;   Female Pattern Baldness
Interventions: Device: HairMax LaserComb;   Device: Sham Device
12 Recruiting Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
Conditions: Alopecia;   Breast Cancer
Intervention: Device: elasto-gel cap
13 Recruiting Treatment of Androgenetic Alopecia in Females, 12 Beam
Conditions: Androgenetic Alopecia;   Hair Loss;   Female Pattern Baldness
Interventions: Device: HairMax LaserComb 2009 model 12 beam;   Device: Sham Device
14 Not yet recruiting The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata
Condition: Alopecia Areata
Interventions: Drug: Botulinum toxin type A;   Drug: Triamcinolone acetonide
15 Recruiting START: Swiss Taxotere Alopecia Prevention Trial
Conditions: Neoplasms;   Alopecia
Interventions: Device: Paxman Cooling Machine;   Device: Cold Caps
16 Recruiting Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: Triamcinolone Acetonide 10 mg/mL (Kenalog-10)
17 Recruiting Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Condition: Alopecia
Interventions: Drug: 7% (w/v) Tempol alcohol-based gel (MTS-01);   Drug: alcohol-based gel
18 Recruiting Alopecia Areata Registry
Conditions: Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis;   Autoimmune Hair Loss;   Alopecia Partialis
Intervention:
19 Not yet recruiting Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
Condition: Alopecia Areata
Intervention: Drug: Intracutaneous injections of Botulinum Toxin A (Botox), 0.1 cc per injection site, which equals 10 units

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services